v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating activities      
Net (loss) income from continuing operations $ (82,286) $ (299,402) $ 15,653
Adjustments to reconcile net (loss) income to net cash used in operating activities      
Non-cash adjustments of inventory 985 9,082 4,941
Accretion expense 10,674 9,740 4,273
Depreciation of property and equipment and amortization of intangible assets 20,382 22,624 12,789
Amortization of operating right-of-use assets 2,319 1,980 1,074
Share-based compensation 7,707 12,162 14,941
Deferred income tax expense (18,615) (35,299) (1,245)
Gain on fair value of warrants and purchase option derivative (322) (58,523) (57,904)
Gain on disposal of fixed assets (1,914)    
(Gain) loss from revaluation of contingent consideration (645) (1,061) 3,584
Impairment of goodwill and intangible assets 55,993 311,084 8,640
Impairment of property and equipment 2,079 1,089 312
(Gain) loss on derecognition of right of use assets and lease termination (1,217) 1,163 3,278
Release of indemnification asset   3,973 4,504
Forgiveness of loan principal and interest     (1,414)
Bad debt expense   9,941  
Employee Retention Credits recorded in other income   (9,440)  
Gain on extinguishment of debt   (4,153)  
Debt modification fees expensed   2,507  
Unrealized and realized foreign exchange (gain) loss (53) 712 4,654
Unrealized and realized loss (gain) on investments 2,603 (43) (6,192)
Changes in operating assets and liabilities      
Receivables (9,259) 2,862 (3,209)
Inventory (5,185) 676 (18,508)
Prepaid expense and other current assets 1,198 856 (1,649)
Deposits 500 3,666  
Other assets 797 711 (726)
Accounts payable and accrued liabilities and other payables 644 (12,103) 2,820
Operating lease liability (1,861) (1,314) (663)
Other liability (2,070) (13,846) 6,440
Uncertain tax position liabilities 66,404 3,905 (2,690)
Contingent consideration payable   (410) (11,394)
Corporate income tax payable (18,946) 14,598 (6,938)
Deferred revenue 1,219 428 467
Net cash provided by (used in) operating activities- continuing operations 31,131 (21,835) (24,162)
Net cash used in operating activities- discontinued operations (3,660) (4,288) (7,653)
Net cash provided by (used in) operating activities 27,471 (26,123) (31,815)
Investing activities      
Investment in property and equipment (7,762) (39,631) (39,835)
Investment in intangible assets (1,666) (2,261) (376)
Principal payments received on lease receivable   515 677
Distributions of earnings from associates     469
Investment in NJ partnership     (50,000)
Deposits for business acquisition   (1,065)  
Success fees related to ATC and other investment (3,012)    
Payment for land contracts (1,275) (1,271)  
Cash portion of consideration (paid in) received acquisitions, net of cash of acquired (16,789) 16,227 (42,736)
Net cash used in investing activities- continuing operations (30,504) (27,486) (131,801)
Net cash provided by (used in) investing activities - discontinued operations 14,285 (93) (620)
Net cash used in investing activities (16,219) (27,579) (132,421)
Financing activities      
Transfer of Employee Retention Credit 12,677    
Proceeds from loans payable, net of transaction costs 23,869 43,419 766
Proceeds from options and warrants exercised 98 24,342 30,785
Loan principal paid (50,154) (42,221) (4,500)
Loan amendment fee paid and prepayment premium paid (1,178) (4,977)  
Tax distributions to NJ partners 0 (1,539)  
Capital distributions paid to non-controlling interests (11,621) (7,550) (53)
Payments of contingent consideration   (6,630) (18,274)
Proceeds from private placement 20,822   173,477
Payments made for financing obligations and finance lease (1,474) (1,125)  
Net cash (used in) provided by financing activities- continuing operations (6,961) 3,719 182,201
Net cash used in financing activities- discontinued operations (5,539)    
Net cash (used in) provided by financing activities (12,500) 3,719 182,201
Net (decrease) increase in cash and cash equivalents and restricted cash during the year (1,248) (49,983) 17,965
Net effects of foreign exchange (168) (2,896) 2,451
Cash and cash equivalents and restricted cash, beginning of the year 26,763 79,642 59,226
Cash and cash equivalents and restricted cash, end of the year 25,347 26,763 79,642
Supplemental disclosure with respect to cash flows      
Income taxes (refund received) paid (3,280) 9,917 37,060
Interest paid 23,037 26,840 21,171
Lease termination fee paid 379 3,300  
Non-cash transactions      
Equity and warrant liability issued as consideration for acquisition 8,601 338,739 34,427
Shares issued- Canopy USA arrangement   55,520  
Warrant issued as consideration for services 1,000    
Promissory note issued as consideration for acquisitions 11,689 10,000 8,839
Shares issued for legal and liability settlement 794 264  
Accrued capital purchases $ 1,494 $ 2,187 $ 450

Source

HTML PDF
XBRL
ZIP